Reliance Money has recommended a buy rating on Orchid Chemicals and Pharmaceuticals with a target price of Rs 86 in its February 2, 2009 research report. "Orchid Chemicals & Pharmaceuticals Ltd (Orchid) reported flat revenues at Rs 3215 million in its consolidated revenues, as there were no major product launch during the quarter and the US operation witnessed a overall slowdown. We foresee a sound long term prospects of the company and put a BUY rating with a revised target price of Rs 86 (from earlier Rs 92). At this TP, the stock would available at 5x FY10EPS and 6x FY10 EV/EBITDA," says Reliance Money's research report.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

To read the full report click on the attachment......